Spectrum Oncology Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2008.

2008 Mumbai, Maharashtra, India Under Liquidation

Last Updated: July 26, 2025

About Spectrum Oncology Private Limited

Spectrum Oncology Private Limited, a under liquidation private limited company, was established on 01 May 2008 in Mumbai, Maharashtra, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U51397MH2008PTC181835. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.19 M.

Formerly known as Oncorx Pharma Private Limited. It upholds a compliant status. Its leadership includes Arun Shankar Nanivadekar (Director), Hemanshu Lalitbhai Kapadia (Irp/Rp/Liquidator), Purvish Mahendra Parikh (Director). Past directors included Agya Singh Kochar, Arun Shankar Nanivadekar, Bhavana Sharadchandra Doshi. Its latest AGM occurred on 05 July 2023, with the balance sheet filed on 31 March 2023. It is based at Ofc No 1 Sadhana Bldg Gr Flr 207, David Barreto Rd Opp Wadala Stn Wadala West, Mumbai, Maharashtra, 400031.

Company Details

CIN/LLPIN
U51397MH2008PTC181835
Registration Number
181835
Incorporation Date
01 May 2008
Authorized Capital
₹1.00 M
Paid-Up Capital
₹0.19 M
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Under Liquidation

Key Metrics

Authorised Capital ₹ 1.00 M as on 26-07-2025
Paid Up Capital ₹ 0.19 M as on 26-07-2025
Company Age 17 Year, 10 Months
Last Filing with ROC 31 Mar 2023
Revenue Growth **** 14.03% (FY 2023)
Profit Growth **** 6.09% (FY 2023)
Ebitda **** -15.23% (FY 2023)
Net Worth -11.99% (FY 2023)
Total Assets -3.31% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Spectrum Oncology Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Spectrum Oncology Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Arun Shankar Nanivadekar	Director	30 Jun 2009	Current
Hemanshu Lalitbhai Kapadia	Irp/Rp/Liquidator	09 May 2024	Current
Purvish Mahendra Parikh	Director	30 Jun 2009	Current
Satyanarain Rameshwardas Agarwala	Director	01 May 2008	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	21 Dec 2012	Past
Pramod Abcsdd	Director Appointed In Casual Vacancy	30 Sep 2009	Past
Pramod Abcsdd	Director	20 Jan 2009	Past
Pramod Abcsdd	Director	20 Jan 2009	Past
Pramod Abcsdd	Director	28 Sep 2012	Past
Pramod Abcsdd	Director	04 Jan 2016	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Spectrum Oncology.

Spectrum Oncology Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.03% increase. The company also saw a slight improvement in profitability, with a 6.09% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.99%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

14.03%

*******

Revenue from Operations

*******

13.43%

*******

Total Assets

*******

-3.31%

*******

Profit or Loss

*******

6.09%

*******

Net Worth

*******

-11.99%

*******

EBITDA

*******

-15.23%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Spectrum Oncology?

In 2023, Spectrum Oncology had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Spectrum Oncology?

Unlock and access historical data on people associated with Spectrum Oncology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Spectrum Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spectrum Oncology's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Spectrum Oncology

Recent Activity within the Organization

Director Appointment

Hemanshu Lalitbhai Kapadia was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 09 May 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.
09 May 2024
Annual General Meeting

Spectrum Oncology Private Limited last Annual general meeting of members was held on 05 Jul 2023 as per latest MCA records. was recorded as a recent event.
05 Jul 2023
Balance Sheet

Progress on Spectrum Oncology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was documented.
31 Mar 2023
Director Appointment

The activity Arun Shankar Nanivadekar was appointed as a Director was appointed as a Director on 30 Jun 2009 & has been associated with this company since 16 years 8 months . was completed.
30 Jun 2009
Director Appointment

The activity Purvish Mahendra Parikh was appointed as a Director was appointed as a Director on 30 Jun 2009 & has been associated with this company since 16 years 8 months . was completed.
30 Jun 2009
Director Appointment

Satyanarain Rameshwardas Agarwala was appointed as a Director was appointed as a Director on 01 May 2008 & has been associated with this company since 17 years 10 months . was recorded as a recent event.
01 May 2008

Explore recent activity and updates - View Recent Activity